Our findings showed no contributions of GRIN2A and GRIN2B polymorphisms into genetic architecture of schizophrenia’s clinical heterogeneity concerning different leading symptoms (negative or positive) or the course of schizophrenia (continuous or episodic) in our Russian population of the Siberian region. The gene discussed is GRIN2B; the disease is schizophrenia.